Astrazeneca (AZN) Net Cash Flow Growth (1y) (2010 - 2026)
Analysis
Astrazeneca (AZN) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn | 7.81% |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn | -103.68% |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - | - |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - | - |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -103.68% |
| Mar 31, 2026 | -36.30% |
| Dec 31, 2025 | -48.09% |
| Sep 30, 2025 | 67.63% |
| Jun 30, 2025 | 500.00% |
| Mar 31, 2025 | 3,269.86% |
| Dec 31, 2024 | -73.33% |
| Jun 30, 2024 | -82.22% |
| Mar 31, 2024 | -96.13% |
| Dec 31, 2023 | 6.89% |
| Jun 30, 2023 | 167.41% |
| Mar 31, 2023 | -38.41% |
| Dec 31, 2022 | 337.66% |
| Jun 30, 2022 | -31.71% |
| Mar 31, 2022 | 23.10% |
| Dec 31, 2021 | -231.59% |
| Sep 30, 2021 | -804.11% |
| Jun 30, 2021 | -44.78% |
| Mar 31, 2021 | 1,581.76% |
| Dec 31, 2020 | 1,836.00% |